Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder
Key facts
- Who runs it
- Asad Ullah Jan
- Where
- Pakistan2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 6 May 2025
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Eye Movement Desensitization and Reprocessing Therapy
- Selective serotonin reuptake inhibitors
- Record updated
- 7 May 2026
Who can take part
- Age
- 18 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 18-60 years
- Clinical diagnosis of Post-Traumatic Stress Disorder (PTSD)
- Duration of illness ≥ 6 months
- Able to provide informed consent
Who cannot take part
- Concurrent psychotherapy or psychiatric medication (except study-assigned SSRI)
- History of psychotic disorder or bipolar disorder
- Current substance abuse or dependence
- Active suicidal ideation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial aims to compare the efficacy of Eye Movement Desensitization and Reprocessing (EMDR) therapy versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the treatment of Post-Traumatic Stress Disorder (PTSD). Adult patients diagnosed with PTSD will be randomly assigned to receive either EMDR therapy or SSRIs for a period of six weeks. The primary outcome is the rate of remission as measured by validated PTSD symptom severity scales at Week 6. Secondary outcomes include changes in functional impairment and patient-reported quality of life. The study seeks to determine whether EMDR therapy is a non-pharmacological alternative to SSRIs for achieving symptom remission in PTSD.
The 2 groups in the trial
- EMDR TherapyTreatment being tested
Participants will receive Eye Movement Desensitization and Reprocessing (EMDR) therapy over six weeks.
Treatment: Eye Movement Desensitization and Reprocessing Therapy
- Selective Serotonin Reuptake Inhibitors (SSRIs)TreatmentExisting treatment, for comparison
Participants will receive selective serotonin reuptake inhibitors (SSRIs) such as Sertraline over six weeks.
Treatment: Selective serotonin reuptake inhibitors
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder: A Randomized Controlled Trial
- Record updated
- 7 May 2026